{
  "issued_date": "2013-06-19", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON286939", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2013/042", 
    "Audience": "Healthcare professionals", 
    "Published": "19 June 2013 at 15:00", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "5", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "FA573", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286817.pdf", 
      "filename": "downloads/2a7d94aa0e9b9bf07ba25efbc6e6463836bb11d7/con286817.pdf", 
      "original_filename": "con286817.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA573", 
      "assetid": 1, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286817.pdf", 
      "filename": "downloads/2a7d94aa0e9b9bf07ba25efbc6e6463836bb11d7/con286817.pdf", 
      "original_filename": "con286817.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA574", 
      "assetid": 2, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286920.pdf", 
      "filename": "downloads/202ae94b17d8b05c1b9face11e55067e54e363ec/con286920.pdf", 
      "original_filename": "con286920.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA574", 
      "assetid": 3, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286920.pdf", 
      "filename": "downloads/202ae94b17d8b05c1b9face11e55067e54e363ec/con286920.pdf", 
      "original_filename": "con286920.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA578", 
      "assetid": 4, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286764.pdf", 
      "filename": "downloads/e2c0d9e72959a211ab2d3c0c07a7491e6ced6b89/con286764.pdf", 
      "original_filename": "con286764.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA579", 
      "assetid": 5, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286822.pdf", 
      "filename": "downloads/d35ae9fe4f16cafde3766d6fcc6d7cf3641ffc6c/con286822.pdf", 
      "original_filename": "con286822.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA579", 
      "assetid": 6, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286822.pdf", 
      "filename": "downloads/d35ae9fe4f16cafde3766d6fcc6d7cf3641ffc6c/con286822.pdf", 
      "original_filename": "con286822.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA535", 
      "assetid": 7, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con146673.pdf", 
      "filename": "downloads/6d55654317bab9823b948f77b7ba2ffff07087d2/con146673.pdf", 
      "original_filename": "con146673.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA573", 
      "assetid": 8, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286817.pdf", 
      "filename": "downloads/2a7d94aa0e9b9bf07ba25efbc6e6463836bb11d7/con286817.pdf", 
      "original_filename": "con286817.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA574", 
      "assetid": 9, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286920.pdf", 
      "filename": "downloads/202ae94b17d8b05c1b9face11e55067e54e363ec/con286920.pdf", 
      "original_filename": "con286920.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA535", 
      "assetid": 10, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con146673.pdf", 
      "filename": "downloads/6d55654317bab9823b948f77b7ba2ffff07087d2/con146673.pdf", 
      "original_filename": "con146673.pdf"
    }, 
    {
      "content_type": "application/pdf", 
      "title": "FA579", 
      "assetid": 11, 
      "original_url": "http://www.mhra.gov.uk/home/groups/fsn/documents/fieldsafetynotice/con286822.pdf", 
      "filename": "downloads/d35ae9fe4f16cafde3766d6fcc6d7cf3641ffc6c/con286822.pdf", 
      "original_filename": "con286822.pdf"
    }
  ], 
  "body": "## Device\n\nImplantable drug pumps and accessories:  \nSynchroMed II and SynchroMed EL (all models)  \nSutureless connector intrathecal catheter products (models 8709SC, 8731SC, 8596SC, 8578)\n\nManufactured by Medtronic.\n\n## Problem\n\nRisk of drug under- or overdose due to various issues with these drug pumps.\n\nMedtronic has recently issued four Field Safety Notices (FSN) related to the SynchroMed II and SynchroMed EL implantable drug pumps and accessories:  \n  \n  1. The first FSN (Manufacturer reference: [ASSET_TAG](#ASSET0) (362Kb)) confirms a serious risk associated with the priming bolus function. Unintentional mixing of drug and non-drug fluids (including cerebrospinal fluid and sterile water) during the priming bolus can pose a risk of overdose. A subsequent risk of underdose exists following administration of the priming bolus. Detailed advice on the management of patients during pump priming is provided in [ASSET_TAG](#ASSET1) (362Kb).  \n  2. The second FSN ([ASSET_TAG](#ASSET2) (356Kb)) confirms a risk of an electrical short circuit occurring in the feed-through, which provides an electrically insulated path for current to flow from the electronic circuitry to the motor. This issue typically presents itself as a motor stall or low battery reset / alarm and may result in an underdose. Underdose of drug can lead to return of underlying symptoms and / or withdrawal syndrome, a life\u2011threatening condition for patients receiving intrathecal baclofen therapy. Detailed advice on setting / interpreting alarms and reading alarm event logs is provided in [ASSET_TAG](#ASSET3) (356Kb).  \n  3. The third FSN ([ASSET_TAG](#ASSET4) (774Kb)) has been issued to notify clinicians that the product labelling has been updated to include the advice on pocket fills, which was originally given in an earlier FSN ([FA496](http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/fieldsafetynotices/FieldSafetyNoticesformedicaldevices/CON106020)).  \n  4. The fourth FSN ([ASSET_TAG](#ASSET5) (303Kb)) confirms the recall of certain connectors manufactured before a recent design improvement. These \u2018Sutureless Connector Intrathecal Catheter connectors\u2019 may exhibit a greater potential for misalignment and subsequent occlusion, which can lead to an underdose. Full details of how to identify devices for return are provided in [ASSET_TAG](#ASSET6) (303Kb).  \n  \nNote: An earlier FSN ([ASSET_TAG](#ASSET7) (78Kb), issued in March 2012) relating to erroneous end of service messages, which can result in a drug underdose, also remains relevant as the manufacturer\u2019s software solution has not yet been implemented\n\nAll these FSNs are available on the MHRA website.\n\n## Action  \n  \n  * Be aware that Medtronic has recently issued four Field Safety Notices concerning these products. The MHRA has summarised and prioritised the required actions below.  \n  * Ensure you follow this advice on device and patient management and, also, the return of sutureless catheter connectors to Medtronic.  \n  \nSynchroMed II and EL:  \n  \n  * Prime all new pumps prior to implant in the patient or connection to the catheter to reduce the risk of overdose.  \n  * Monitor all patients closely after initiation of therapy for up to 24 hours, dependent on specific drug guidelines (see FSN [ASSET_TAG](#ASSET8) (362Kb)).  \n  * Avoid the use of concomitant drugs during therapy initiation that may cause respiratory or CNS depression.  \n  * Consider providing an oral baclofen supplement to patients receiving intrathecal baclofen, until the optimal intrathecal dose is obtained.  \n  * Reinforce with patients and caregivers information on the various pump alarms (see FSN [ASSET_TAG](#ASSET9) (356Kb)) and on the signs and symptoms of withdrawal due to therapy cessation.  \n  * Continue to monitor patients for the return of baseline symptoms for the life of the implant as this could indicate pump failure due to an electrical short.  \n  * Continue to follow advice on the management of device erroneous end of service messages contained within the earlier FSN (see FSN [ASSET_TAG](#ASSET10) (78Kb)) until a software upgrade has been installed.  \n  \nSutureless catheter products (used with the SynchroMed pump):  \nReturn all sutureless connector intrathecal catheter products that have a use by date preceding 25 August 2014 (see FSN [ASSET_TAG](#ASSET11) (303Kb)).\n\n### Action by\n\nAll staff who manage patients implanted with drug pumps.\n\n## Distribution\n\nThis MDA has been sent to:  \n  \n  * Care Quality Commission (CQC) (headquarters) for information  \n  * Clinical commissioning groups (CCGs)  \n  * HSC trusts in Northern Ireland (chief executives)  \n  * NHS boards and trusts in Wales (chief executives)  \n  * NHS boards in Scotland (equipment coordinators)  \n  * NHS England area teams (for information)  \n  * NHS trusts in England (chief executives)  \n  \n### Onward distribution\n\nPlease bring this notice to the attention of relevant employees in your establishment. \u00a0  \nBelow is a suggested list of recipients.\n\nTrusts  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * A&E departments  \n  * Anaesthesia, directors of  \n  * Anaesthetic medical staff  \n  * Anaesthetic nursing staff  \n  * Anaesthetists  \n  * Chronic pain teams  \n  * Clinical governance leads  \n  * Medical directors  \n  * Neurologists  \n  * Neurosurgeons  \n  * Pain consultants  \n  * Spinal surgeons  \n  * Theatres  \n  \n### Independent distribution\n\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \nThis alert should be read by:  \n  \n  * Hospitals in the independent sector  \n  * Private medical practitioners  \n  \nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health\u2019s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk)\u00a0and requesting this facility.\n\n## Manufacturer Contact\n\nManufacturer  \nMedtronic Ltd  \nLezlie Bridge  \nBuilding 9  \nCroxley Green Business Park  \nHatters Lane  \nWatford  \nWD18 8WW  \nTel:\u00a0\u00a0\u00a0 07740 899 216  \nFax:\u00a0\u00a0 01923 225 273  \nEmail:\u00a0\u00a0\u00a0 [vigilance.eu@medtronic.com](mailto:vigilance.eu@medtronic.com)\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk)\n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2013/042 or 2013/005/031/081/018\n\nTechnical aspects  \nMichelle Kelly or Simon Holmes  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0\u00a0\u00a0 020 3080 7145 or 7240  \nFax:\u00a0\u00a0 020 8754 3965  \nEmail:\u00a0\u00a0\u00a0 [michelle.kelly@mhra.gsi.gov.uk](mailto:michelle.kelly@mhra.gsi.gov.uk) or [simon.holmes@mhra.gsi.gov.uk](mailto:ailto:simon.holmes@mhra.gsi.gov.uk)\n\nFor clinical aspects please contact the Clinical Team  \nMedicines & Healthcare Products Regulatory Agency  \nFloor 4  \n151 Buckingham Palace Road  \nLondon SW1W 9SZ  \nTel:\u00a0\u00a0\u00a0 020 3080 7032  \nFax:\u00a0\u00a0 020 8754 3965  \nEmail:\u00a0\u00a0\u00a0 [kayleigh.purdon@mhra.gsi.gov.uk](mailto:kayleigh.purdon@mhra.gsi.gov.uk)\n\n### How to report adverse incidents\n\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \nFurther information about CAS can be found [on the CAS website](https://www.cas.dh.gov.uk/Home.aspx) (external link)\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald BT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900  \nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n### How to report adverse incidents in Northern Ireland\n\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link)  \nFurther information about SABS can be found [on the SABS website](http://sabs.dhsspsni.gov.uk/)(external link)\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh EH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link)\n\n## Wales\n\nEnquiries in Wales should be addressed to:  \n  \nImproving Patient Safety Team  \nMedical Directorate  \nWelsh Government  \nCathays Park  \nCardiff CF10 3NQ\n\nTel: 029 2082 3922  \nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><span>Implantable drug pumps and accessories:<br>\nSynchroMed II and SynchroMed EL (all models)<br>\nSutureless connector intrathecal catheter products (models 8709SC, 8731SC, 8596SC, 8578)</span></p>\n\n<p><span>Manufactured by Medtronic.</span></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<p><span>Risk of drug under- or overdose due to various issues with these drug pumps.</span></p>\n\n<p>Medtronic has recently issued four Field Safety Notices (FSN) related to the SynchroMed II and SynchroMed EL implantable drug pumps and accessories:</p>\n\n<ol>\n<li>The first FSN (Manufacturer reference: <a href=\"#ASSET0\">ASSET_TAG</a> (362Kb)) confirms a serious risk associated with the priming bolus function. Unintentional mixing of drug and non-drug fluids (including cerebrospinal fluid and sterile water) during the priming bolus can pose a risk of overdose. A subsequent risk of underdose exists following administration of the priming bolus. Detailed advice on the management of patients during pump priming is provided in <a href=\"#ASSET1\">ASSET_TAG</a> (362Kb).</li>\n\n<li>The second FSN (<a href=\"#ASSET2\">ASSET_TAG</a> (356Kb)) confirms a risk of an electrical short circuit occurring in the feed-through, which provides an electrically insulated path for current to flow from the electronic circuitry to the motor. This issue typically presents itself as a motor stall or low battery reset / alarm and may result in an underdose. Underdose of drug can lead to return of underlying symptoms and / or withdrawal syndrome, a life&#8209;threatening condition for patients receiving intrathecal baclofen therapy. Detailed advice on setting / interpreting alarms and reading alarm event logs is provided in <a href=\"#ASSET3\">ASSET_TAG</a> (356Kb).</li>\n\n<li>The third FSN (<a href=\"#ASSET4\">ASSET_TAG</a> (774Kb)) has been issued to notify clinicians that the product labelling has been updated to include the advice on pocket fills, which was originally given in an earlier FSN (<a href=\"http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/fieldsafetynotices/FieldSafetyNoticesformedicaldevices/CON106020\">FA496</a>).</li>\n\n<li>The fourth FSN (<a href=\"#ASSET5\">ASSET_TAG</a> (303Kb)) confirms the recall of certain connectors manufactured before a recent design improvement. These &#8216;Sutureless Connector Intrathecal Catheter connectors&#8217; may exhibit a greater potential for misalignment and subsequent occlusion, which can lead to an underdose. Full details of how to identify devices for return are provided in <a href=\"#ASSET6\">ASSET_TAG</a> (303Kb).</li>\n</ol>\n\n<p>Note: An earlier FSN (<a href=\"#ASSET7\">ASSET_TAG</a> (78Kb), issued in March 2012) relating to erroneous end of service messages, which can result in a drug underdose, also remains relevant as the manufacturer&#8217;s software solution has not yet been implemented</p>\n\n<p>All these FSNs are available on the MHRA website.</p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n\t\t\t\t\t\r\n\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<ul>\n<li><span>Be aware that Medtronic has recently issued four Field Safety Notices concerning these products. The MHRA has summarised and prioritised the required actions below.</span></li>\n\n<li><span>Ensure you follow this advice on device and patient management and, also, the return of sutureless catheter connectors to Medtronic.</span></li>\n</ul>\n\n<p><span>SynchroMed II and EL:</span></p>\n\n<ul type=\"disc\">\n<li>Prime all new pumps prior to implant in the patient or connection to the catheter to reduce the risk of overdose.</li>\n\n<li>Monitor all patients closely after initiation of therapy for up to 24 hours, dependent on specific drug guidelines (see FSN <a href=\"#ASSET8\">ASSET_TAG</a> (362Kb)).</li>\n\n<li>Avoid the use of concomitant drugs during therapy initiation that may cause respiratory or CNS depression.</li>\n\n<li>Consider providing an oral baclofen supplement to patients receiving intrathecal baclofen, until the optimal intrathecal dose is obtained.</li>\n\n<li>Reinforce with patients and caregivers information on the various pump alarms (see FSN <a href=\"#ASSET9\">ASSET_TAG</a> (356Kb)) and on the signs and symptoms of withdrawal due to therapy cessation.</li>\n\n<li>Continue to monitor patients for the return of baseline symptoms for the life of the implant as this could indicate pump failure due to an electrical short.</li>\n\n<li>Continue to follow advice on the management of device erroneous end of service messages contained within the earlier FSN (see FSN <a href=\"#ASSET10\">ASSET_TAG</a> (78Kb)) until a software upgrade has been installed.</li>\n</ul>\n\n<p><span>Sutureless catheter products</span> (used with the SynchroMed pump):<br>\nReturn all sutureless connector intrathecal catheter products that have a use by date preceding 25 August 2014 (see FSN <a href=\"#ASSET11\">ASSET_TAG</a> (303Kb)).</p>\n\n<h3>Action by</h3>\n\n<p>All staff who manage patients implanted with drug pumps.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been sent to:</p>\n\n<ul>\n<li>Care Quality Commission (CQC) (headquarters) for information</li>\n\n<li>Clinical commissioning groups (CCGs)</li>\n\n<li>HSC trusts in Northern Ireland (chief executives)</li>\n\n<li>NHS boards and trusts in Wales (chief executives)</li>\n\n<li>NHS boards in Scotland (equipment coordinators)</li>\n\n<li>NHS England area teams (for information)</li>\n\n<li>NHS trusts in England (chief executives)</li>\n</ul>\n\n<h3>Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment. &#160;<br>\nBelow is a suggested list of recipients.</p>\n\n<p><span>Trusts</span><br>\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p>\n\n<ul>\n<li>A&amp;E departments</li>\n\n<li>Anaesthesia, directors of</li>\n\n<li>Anaesthetic medical staff</li>\n\n<li>Anaesthetic nursing staff</li>\n\n<li>Anaesthetists</li>\n\n<li>Chronic pain teams</li>\n\n<li>Clinical governance leads</li>\n\n<li>Medical directors</li>\n\n<li>Neurologists</li>\n\n<li>Neurosurgeons</li>\n\n<li>Pain consultants</li>\n\n<li>Spinal surgeons</li>\n\n<li>Theatres</li>\n</ul>\n\n<h3>Independent distribution</h3>\n\n<p><span>Establishments registered with the Care Quality Commission (CQC) (England only)</span><br>\nThis alert should be read by:</p>\n\n<ul>\n<li>Hospitals in the independent sector</li>\n\n<li>Private medical practitioners</li>\n</ul>\n\n<p><span>Please note:</span> CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health&#8217;s Central Alerting System (CAS) by sending an email to: <a href=\"mailto:safetyalerts@dh.gsi.gov.uk\" added=\"null\">safetyalerts@dh.gsi.gov.uk</a>&#160;and requesting this facility.</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\t<p><span>Manufacturer</span><br>\nMedtronic Ltd<br>\nLezlie Bridge<br>\nBuilding 9<br>\nCroxley Green Business Park<br>\nHatters Lane<br>\nWatford<br>\nWD18 8WW<br>\nTel:&#160;&#160;&#160; 07740 899 216<br>\nFax:&#160;&#160; 01923 225 273<br>\nEmail:&#160;&#160;&#160; <a href=\"mailto:vigilance.eu@medtronic.com\">vigilance.eu@medtronic.com</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\" added=\"null\">dts@mhra.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2013/042</span> or <span>2013/005/031/081/018</span></p>\n\n<p><span>Technical aspects</span><br>\nMichelle Kelly or Simon Holmes<br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;&#160;&#160; 020 3080 7145 or 7240<br>\nFax:&#160;&#160; 020 8754 3965<br>\nEmail:&#160;&#160;&#160; <a href=\"mailto:michelle.kelly@mhra.gsi.gov.uk\">michelle.kelly@mhra.gsi.gov.uk</a> or <a href=\"mailto:ailto:simon.holmes@mhra.gsi.gov.uk\">simon.holmes@mhra.gsi.gov.uk</a></p>\n\n<p><span>For clinical aspects please contact the Clinical Team</span><br>\nMedicines &amp; Healthcare Products Regulatory Agency<br>\nFloor 4<br>\n151 Buckingham Palace Road<br>\nLondon SW1W 9SZ<br>\nTel:&#160;&#160;&#160; 020 3080 7032<br>\nFax:&#160;&#160; 020 8754 3965<br>\nEmail:&#160;&#160;&#160; <a href=\"mailto:kayleigh.purdon@mhra.gsi.gov.uk\">kayleigh.purdon@mhra.gsi.gov.uk</a></p>\n\n<h3>How to report adverse incidents</h3>\n\n<p>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\" added=\"null\">Reporting adverse incidents involving medical devices</a><br>\nFurther information about CAS can be found <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\" added=\"null\">on the CAS website</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<p>Northern Ireland Adverse Incident Centre<br>\nHealth Estates Investment Group<br>\nRoom 17<br>\nAnnex 6<br>\nCastle Buildings<br>\nStormont Estate<br>\nDundonald BT4 3SQ</p>\n\n<p>Tel: 02890 523 704<br>\nFax: 02890 523 900<br>\nEmail: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\" added=\"null\">NIAIC@dhsspsni.gov.uk</a></p>\n\n<h3>How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" added=\"null\">NIAIC website</a> (external link)<br>\nFurther information about SABS can be found <a href=\"http://sabs.dhsspsni.gov.uk/\" added=\"null\">on the SABS website</a>(external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<p>Incident Reporting and Investigation Centre<br>\nHealth Facilities Scotland<br>\nNHS National Services Scotland<br>\nGyle Square<br>\n1 South Gyle Crescent<br>\nEdinburgh EH12 9EB</p>\n\n<p>Tel: 0131 275 7575<br>\nFax: 0131 314 0722</p>\n\n<p>Email: <a href=\"mailto:nss.iric@nhs.net\" added=\"null\">nss.iric@nhs.net</a></p>\n\n<p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\" added=\"null\">Health Facilities Scotland Incident Reporting and Investigation Centre (IRIC)</a> (external link)</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries in Wales should be addressed to:<br>\n<br>\nImproving Patient Safety Team<br>\nMedical Directorate<br>\nWelsh Government<br>\nCathays Park<br>\nCardiff CF10 3NQ</p>\n\n<p>Tel: 029 2082 3922<br>\nEmail: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\" added=\"null\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: Implantable drug pumps and accessories manufactured by Medtronic (MDA/2013/042)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": [
    "anaesthetics", 
    "theatre-practitioners"
  ]
}